Biosynex Logo

Biosynex

Designs and distributes medical diagnostic solutions, including rapid tests and devices.

ALBIO | PA

Overview

Corporate Details

ISIN(s):
FR0011005933
LEI:
969500H4BGE1HBLGP566
Country:
France
Address:
22 BOULEVARD SEBASTIEN BRANT, 67400 ILLKIRCH-GRAFFENSTADEN

Description

Biosynex is a company that specializes in the design, manufacture, and distribution of medical diagnostic solutions. Its core product line consists of Rapid Diagnostic Tests (RDTs) for both professional use in clinical settings and for self-testing by the general public. The professional portfolio includes point-of-care (POC) instruments, molecular biology diagnostics (such as PCR tests), and a wide array of immunodiagnostic assays. For the consumer market, Biosynex offers various self-tests and a range of prevention and monitoring devices, including thermometers, blood pressure monitors, and pulse oximeters. The company focuses on providing simple, rapid, and effective tools for screening, diagnosis, and prevention.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 18:00
BIOSYNEX SA: CHEMBIO DIAGNOSTIC SYSTEMS INC., FILIALE DE BIOSYNEX, REÇOIT UNE S…
French 331.8 KB
2025-11-14 18:00
BIOSYNEX SA: CHEMBIO DIAGNOSTIC SYSTEMS INC., FILIALE DE BIOSYNEX, RECOIT UNE S…
French 27.2 KB
2025-10-22 18:00
BIOSYNEX SA: RESULTATS SEMESTRIELS 2025
French 430.2 KB
2025-10-22 18:00
BIOSYNEX SA: RESULTATS SEMESTRIELS 2025
French 111.9 KB
2025-09-29 18:00
BIOSYNEX annonce l’ouverture d’une procédure de sauvegarde pour restructurer so…
French 260.3 KB
2025-09-29 18:00
BIOSYNEX annonce louverture dune procedure de sauvegarde pour restructurer son …
French 20.4 KB
2025-09-25 18:00
BIOSYNEX SA: DEPOT D’UNE DEMANDE DE PROCEDURE DE SAUVEGARDE POUR BIOSYNEX ET D’…
French 248.3 KB
2025-09-25 18:00
BIOSYNEX SA: DEPOT DUNE DEMANDE DE PROCEDURE DE SAUVEGARDE POUR BIOSYNEX ET DUN…
French 28.7 KB
2025-08-11 14:34
Franchissement de seuils
French 91.1 KB
2025-07-29 18:45
BIOSYNEX SA: LA FOOD AND DRUG ADMINSITRATION ATTRIBUE LE STATUT “BREAKTHROUGH D…
French 329.1 KB
2025-07-29 18:45
BIOSYNEX SA: LA FOOD AND DRUG ADMINSITRATION ATTRIBUE LE STATUT BREAKTHROUGH DE…
French 28.7 KB
2025-07-17 18:00
BIOSYNEX SA: CHIFFRE D’AFFAIRES DU PREMIER SEMESTRE 2025 : 50,8 M€ (-6%)
French 323.2 KB
2025-07-17 18:00
BIOSYNEX SA: CHIFFRE DAFFAIRES DU PREMIER SEMESTRE 2025 : 50,8 M (-6%)
French 50.6 KB
2025-06-17 18:00
BIOSYNEX SA: LA FOOD AND DRUG ADMINSITRATION ATTRIBUE LE STATUT “BREAKTHROUGH D…
French 329.2 KB
2025-06-17 18:00
BIOSYNEX SA: LA FOOD AND DRUG ADMINSITRATION ATTRIBUE LE STATUT BREAKTHROUGH DE…
French 29.2 KB

Automate Your Workflow. Get a real-time feed of all Biosynex filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Biosynex

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Biosynex via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Annexon, Inc. Logo
Clinical-stage biopharma developing complement medicines by inhibiting C1q.
United States of America
ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes cell therapies and orphan drugs using adult stem cells.
South Korea
065660
Antibiotice S.A. Logo
Pharmaceutical firm manufacturing generic medicines, anti-infectives, and APIs.
Romania
ATB
Apellis Pharmaceuticals, Inc. Logo
Biopharmaceutical company developing therapies by targeting the complement cascade.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Clinical-stage biopharma developing a bee venom drug and AI digital treasury solutions.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Clinical-stage biotech developing biologics for immunological and inflammatory diseases.
United States of America
APGE
Apollomics Inc. Logo
Clinical-stage biotech developing innovative oncology and combination therapies.
United States of America
APLM
Apontis Pharma AG Logo
Develops and markets fixed-dose combination drugs (Single Pills) for chronic diseases.
Germany
APPH
Applied Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel drugs for rare metabolic and CNS diseases.
United States of America
APLT
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologics and biosimilar antibody-based therapeutics.
South Korea
003060

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.